Welcome

Sign out Have a question? We're here to help

Sign out

CEF Income Opportunity ETF FT (FCEF)

$19.58 0.38 (1.98%)

16:00 EDT FCEF Stock Quote Delayed 30 Minutes

Volume:

Previous Close $19.58

Market Cap 29.47M

PE Ratio -

EPS -

Volume (Avg. Vol.) 4,300

Day's Range 19.58 - 19.66

52-Week Range 12.54 - 23.76

Dividend & Yield 1.11 (5.69%)

FCEF Stock Predictions, Articles, and CEF Income Opportunity ETF FT News

From InvestorPlace
From the Web

5 ETFs to Boost Your Income

By Aaron Levitt, InvestorPlace Contributor Mar 12, 2018

Looking to boost your income? ETFs can provide plenty of ways to add much-needed yield. Here are five ETFs to buy today to support your retirement.

5 High-Yield CEF ETFs for Tactical Income Investors

By David Fabian, FMD Capital Management Apr 6, 2017

The five ETFs that hold closed-end funds (CEFs) aren't for everyone, but they're a great source of tactical high-yield income.

Week In Review: China Life Science Companies Raise Nearly $1 Billion Led By Legend's $424 Million US IPO

From Talk Markets Jun 6, 2020

In a successful debut offering, Nanjing Legend Biotech priced its US IPO above the expected range at $23 per ADS, raising $424 million. The company's ADS's climbed 60% higher to $36.60, giving Legend a market capitalization of nearly $5 billion.

Bulls And Bears Of The Week: Gilead, Shopify, Tesla And More

From Benzinga Jun 6, 2020

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included semiconductor and casino stocks. Cruise and...

Income Investors Should Know That Gilead Sciences, Inc. (NASDAQ:GILD) Goes Ex-Dividend Soon

From Simply Wall St Jun 6, 2020

Some investors rely on dividends for growing their wealth, and if you’re one of those dividend sleuths, you might be intrigued to know that Gilead Sciences, Inc. (NASDAQ:GILD) is about<div><a class="permalink" href="https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/income-investors-should-know-that-gilead-sciences-inc-nasdaqgild-goes-ex-dividend-soon-2/">Read More...</a></div>

72 Firms Going Ex-Dividend Next Week, Including Gilead Sciences, Coca-Cola And Merck

From Talk Markets Jun 5, 2020

There are several well known large cap stocks going ex-dividend next week including the following eight Top 100 Dividend Stocks: Gilead Sciences, Eastman Chemical, Hess, Coca-Cola, Merck, Occidental Petroleum, Public Storage and T. Rowe Price.

Antibody Drugs Could Help Curb the Pandemic. What Investors Need to Know.

From Barron's Jun 5, 2020

For investors, news on their progress could cause some drug stocks to be volatile. Among antibody developers, Vir Biotechnology has the most to gain.

Harvard Wins Apple, Twitter Backing on Use of Race in Admissions

From Bloomberg Jun 5, 2020

Intel Corp., Apple Inc. and Amgen Inc. are among more than a dozen companies supporting Harvard University in a fierce legal battle that could shape the use of race in college admissions for decades to come.

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Welcome

CEF Income Opportunity ETF FT (FCEF)

Premium Services

We are always here to help!

Not Yet a Subscriber?

Welcome

Already a subscriber?

Welcome

CEF Income Opportunity ETF FT (FCEF)

FCEF Stock Predictions, Articles, and CEF Income Opportunity ETF FT News

Subscriber Sign in